![Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies | Future Oncology Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.11.8/asset/images/medium/figure2.gif)
Cilengitide: an RGD pentapeptide ανβ3 and ανβ5 integrin inhibitor in development for glioblastoma and other malignancies | Future Oncology
![Cilengitide | CAS:188968-51-6 | Integrin inhibitor for αvβ3 and αvβ5 | High Purity | Manufacturer BioCrick Cilengitide | CAS:188968-51-6 | Integrin inhibitor for αvβ3 and αvβ5 | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCC3942.png)
Cilengitide | CAS:188968-51-6 | Integrin inhibitor for αvβ3 and αvβ5 | High Purity | Manufacturer BioCrick
![Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma | Journal of Clinical Oncology Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2016/jco.2013.48.34.issue-7/jco.2015.63.6563/20161107/images/medium/jco636563ta3.jpeg)
Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma | Journal of Clinical Oncology
![Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway | Journal of Experimental & Clinical Cancer Research | Full Text Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway | Journal of Experimental & Clinical Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1756-9966-27-86/MediaObjects/13046_2008_Article_85_Fig5_HTML.jpg)
Cilengitide induces cellular detachment and apoptosis in endothelial and glioma cells mediated by inhibition of FAK/src/AKT pathway | Journal of Experimental & Clinical Cancer Research | Full Text
![Pharmaceutics | Free Full-Text | Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future? Pharmaceutics | Free Full-Text | Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-01053/article_deploy/html/images/pharmaceutics-14-01053-g001.png)
Pharmaceutics | Free Full-Text | Integrin-αvβ3 as a Therapeutic Target in Glioblastoma: Back to the Future?
![Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial - The Lancet Oncology Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial - The Lancet Oncology](https://www.thelancet.com/cms/attachment/549a64d1-6616-46ab-898e-b29dc37c91ec/gr4_lrg.jpg)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial - The Lancet Oncology
![Full article: Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model Full article: Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model](https://www.tandfonline.com/action/showGraphicalAbstractImage?doi=10.1080%2F21655979.2022.2029236&type=img_lg&id=kbie_a_2029236_uf0001_oc.jpeg)
Full article: Cilengitide, an αvβ3-integrin inhibitor, enhances the efficacy of anti-programmed cell death-1 therapy in a murine melanoma model
![The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus | Cancer Gene Therapy The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus | Cancer Gene Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fcgt.2013.38/MediaObjects/41417_2013_Article_BFcgt201338_Fig7_HTML.jpg)
The integrin inhibitor cilengitide enhances the anti-glioma efficacy of vasculostatin-expressing oncolytic virus | Cancer Gene Therapy
![IJMS | Free Full-Text | Combination Effect of Cilengitide with Erlotinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Human Non-Small Cell Lung Cancer Cells IJMS | Free Full-Text | Combination Effect of Cilengitide with Erlotinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Human Non-Small Cell Lung Cancer Cells](https://pub.mdpi-res.com/ijms/ijms-23-03423/article_deploy/html/images/ijms-23-03423-ag.png?1647941084)
IJMS | Free Full-Text | Combination Effect of Cilengitide with Erlotinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Human Non-Small Cell Lung Cancer Cells
![Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results | Anticancer Research Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/32/10/4213/F1.large.jpg)
Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results | Anticancer Research
![PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70bc1a06a730e1f512f80dac37d33d6c52a1670a/5-TableI-1.png)
PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar
![PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/70bc1a06a730e1f512f80dac37d33d6c52a1670a/6-TableII-1.png)
PDF] Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. | Semantic Scholar
![Frontiers | Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells Frontiers | Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells](https://www.frontiersin.org/files/Articles/639095/fphar-12-639095-HTML-r1/image_m/fphar-12-639095-g007.jpg)
Frontiers | Cyclic RGD Pentapeptide Cilengitide Enhances Efficacy of Gefitinib on TGF-β1-Induced Epithelial-to-Mesenchymal Transition and Invasion in Human Non-Small Cell Lung Cancer Cells
Integrin Inhibitor Cilengitide for the Treatment of Glioblastoma: A Brief Overview of Current Clinical Results
![Cilengitide enhances the in vivo antitumor effect of anti-PD1 antibody... | Download Scientific Diagram Cilengitide enhances the in vivo antitumor effect of anti-PD1 antibody... | Download Scientific Diagram](https://www.researchgate.net/publication/358512824/figure/fig5/AS:1141550230839301@1649178192321/Cilengitide-enhances-the-in-vivo-antitumor-effect-of-anti-PD1-antibody-in-B16-murine.jpg)